CTI index

2 papers1 finding

Humans2

Associations

1

Metabolic dysfunction-associated steatotic liver disease

upin humans1OR 3.62

1 study

CTI index raises the risk of metabolic dysfunction-associated steatotic liver disease in humans (OR 3.62, 95% CI 2.32-5.64).
Humansn = 1,297
The C-Reactive Protein-Triglyceride-Glucose Index as a Biomarker of Metabolic Dysfunction-Associated Steatotic Liver Disease: Results from the Population-Based Italian NUTRI-HEP Cohort
Biomedicines19 Aug 2026

More on Metabolic dysfunction-associated steatotic liver disease

Latest

4 in 12 months

Biomedicines27 Aug

The C-Reactive Protein-Triglyceride-Glucose Index as a Biomarker of Metabolic Dysfunction-Associated Steatotic Liver Disease: Results from the Population-Based Italian NUTRI-HEP Cohort

Cohort study of 1,297 peopleMetabolic dysfunction-associated steatotic liver disease

Medicine15 Aug

Association between the C-reactive protein-triglyceride-glucose index and obstructive sleep apnea risk: Mediating role of body mass index in U.S. adults

Cross-sectional study of 4,564 peopleC-reactive protein

Therapeutic Advances in Endocrinology and Metabolism13 Aug

From traditional to novel: a national cohort study on the predictive value of C-reactive protein-triglyceride-glucose-obesity composite parameters for cardiovascular disease

Cohort study of 7,847 peopleC-reactive protein

Frontiers in Endocrinology12 Aug

Sex differences in the association of the CRP-TyG index with coronary artery disease and long-term mortality in MASLD

Cohort study in peopleTyG